Copy to clipboard 
At the start of this year, holiday decorations were hardly put away and New Year’s resolutions were barely broken before news broke of Stryker divesting its spine implant business to VB Spine and Zimmer Biomet announced an agreement to acquire Paragon 28.
President Trump’s tariff policy created uncertainty in global supply chains and forced orthopedic OEMs and suppliers to revisit the fundamentals of material procurement.
The money raised by Carlsmed and Shoulder Innovations provided an indication that orthopedic investments are set to rebound after an extended lull.
In October, Johnson & Johnson announced plans to spin off its orthopedics business over the next two years to create a standalone company that operates as DePuy Synthes.
Looking ahead, interest surrounding AI and how the technology can improve device design and supply chain management continues to grow. Surgical robots and digital ecosystems remain keys to competing at the top of the spine and joint replacement markets.
We’re excited to see what’s in store in 2026 and how the year plays out.
The infographic is proudly sponsored by Orchid Orthopedics.
